IP Library Granted Patent US 8,883,814
Granted Patent B2
US 8,883,814 · App. 13/307,587 · Granted Nov 11, 2014

Compositions and methods for enhancing brain function

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,883,814
App. No.
13/307,587
Granted
Nov 11, 2014
Kind
B2
Abstract

Compositions and methods are provided that enhance cognition in a human to which the composition is orally administered. Remarkably, clinical studies have proven that contemplated compositions achieve the desired effects using a minimal number of active ingredients at or near threshold active dosages, wherein such compositions almost exclusively comprise huperzine A, vinpocetine or rhodiola, and acetyl-L-carnitine, and optionally further include alpha lipoic acid, rhodiola, and biotin.

Claims (17)

1. A nutritional supplement composition for enhancing cognitive function, comprising:

huperzine A;

vinpocetine; and

acetyl-L-carnitine in a ratio of x:y:z, wherein x is between 0.8 and 1.2, y is between 80 and 120, and z is between 8,000 and 12,000;

wherein the composition is formulated for oral administration such that huperzine A, vinpocetine, and acetyl-L-carnitine, together account for at least 80 wt % of a dosage unit of the nutritional supplement composition.

2. The nutritional composition of claim 1 , and further comprising rhodiola, wherein x is between about 0.9 and about 1.1, y is between about 90 and about 110, and between about 1,800 and about 2,200 for rhodiola, and z is between about 9,000 and about 11,000.

3. The nutritional composition of claim 1 , wherein acetyl-L-carnitine is present in an amount from about 1250 mg to about 2000 mg.

4. The nutritional composition of claim 1 , wherein vinpocetine is present in an amount from about 10 mg to about 30 mg.

5. The nutritional composition of claim 2 , wherein rhodiola is present in an amount from about 250 mg to about 350 mg.

6. The nutritional composition of claim 1 , wherein huperzine A is present in an amount from about 50 mcg to about 200 mcg.

7. The nutritional composition of claim 1 , further comprising alpha lipoic acid in an amount of about 300 mg to about 500 mg.

8. The nutritional composition of claim 1 , further comprising biotin in an amount of about 400 mcg to about 600 mcg.

9. The nutritional composition of claim 1 , wherein the composition is formulated with an enteric coating.

10. The nutritional composition of claim 1 , further comprising an inactive ingredient selected from the group consisting of a carrier, a binder, an excipient, a dye, and combinations thereof.

11. The nutritional composition of claim 1 , wherein huperzine A, vinpocetine, and acetyl-L-carnitine together account for at least 90 wt % of a dosage unit of the composition.

12. The nutritional composition of claim 1 , wherein huperzine A, vinpocetine, and acetyl-L-carnitine together account for at least 95 wt % of the dosage unit of the composition.

13. The nutritional composition of claim 1 , wherein the dosage unit of the composition is equal or less than 1,200 mg.

Assignments (6)
SECURITY INTEREST Recorded Jul 12, 2016
From: KEYVIEW LABS, INC.
To: PACIFIC WESTERN BANK (AS SUCCESSOR IN INTEREST BY MERGER TO SQUARE 1 BANK)
Reel/Frame 039133/0744 →
RELEASE OF INTELLECTUAL PROPERTY SECURITY INTEREST Recorded May 6, 2014
From: BRAIN RESEARCH LABS, LLC
To: KEYVIEW LABS, INC.
Reel/Frame 032827/0391 →
SECURITY AGREEMENT Recorded Feb 8, 2013
From: KEYVIEW LABS, INC.
To: BRAIN RESEARCH LABS, LLC
Reel/Frame 029778/0394 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2013
From: BRAIN RESEARCH LABS, LLC
To: KEYVIEW LABS, INC.
Reel/Frame 029605/0620 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2013
From: REYNOLDS, JOSH
To: 20/20 BRAIN POWER PARTNERS, LLC
Reel/Frame 029591/0060 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2013
From: 20/20 BRAIN POWER PARTNERS, LLC
To: BRAIN RESEARCH LABS, LLC
Reel/Frame 029591/0080 →